GLP1R and diabetes mellitus: Moreover, medications, such as glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose co-transporter-2 inhibitors (SGLT-2i), have been included in the evidence-based treatment of DM, as they provide well documented cardioprotective effects [4,5,6].